Senior Project Manager
Emma Plested is a Senior Project Manager for the Oxford Vaccine Group (OVG). Emma joined the group in January 2005 and is responsible for the effective and efficient Project Management of multiple trials undertaken by OVG, ensuring they are delivered on time, within budget and in compliance with regulatory requirements.
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Frater J. et al, (2021), Lancet HIV, 8, e474 - e485
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M. et al, (2021), Lancet, 397, 881 - 891
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
Carr J. et al, (2020), BMJ Open, 10
The immunogenicity of the U.K. group B meningococcal vaccine (4CMenB) schedule against group B and C meningococcal strains: outcomes of the Sched3 randomised clinical trial.
Davis K. et al, (2020), Lancet Infectious Diseases